Similar Safety and Efficacy of Once- and Twice-Daily Lopinavir/Ritonavir Tablets in Treatment-Experienced HIV-1–Infected Subjects at 48 Weeks
暂无分享,去创建一个
B. Bernstein | J. Gathe | T. Podsadecki | J. Andrade-Villanueva | R. Zajdenverg | L. Fredrick | I. Gaultier | W. Woodward | H. Mingrone | S. Badal-Faesen